CORRECTING and REPLACING Nobel Laureate Leads MedTech Startups Addressing China’s Deadly Virus at OurCrowd Global Investor Summit

JERUSALEM--(BUSINESS WIRE)--Third bullet should read: Eyal Gura, Co-Founder and chairman of Zebra Medical Vision, which has secured 4 FDA clearances for its AI-powered imaging analytics platform (instead of Eyal Gura, founder and chairman of Zebra Medical Vision, which has won 5 FDA approvals for its AI-powered diagnostic imaging tools).

The corrected release reads: 

NOBEL LAUREATE LEADS MEDTECH STARTUPS ADDRESSING CHINA’S DEADLY VIRUS AT OURCROWD GLOBAL INVESTOR SUMMIT

OurCrowd, the global crowdfunding venture investing platform and Israel’s leading venture investor, will feature Dr. Ferid Murad, 1998 Nobel prize winner in medicine, among the experts at the OurCrowd Global Investor Summit on Feb. 13. Murad will discuss how technology can help prevent the development of deadly diseases. The subject has been catapulted back into the headlines with the outbreak of the deadly Coronavirus in China.

Dr. Murad recently joined the board of SaNOtize, an OurCrowd portfolio company using new technology to treat skin and upper respiratory diseases with an infectious component to them. Dr. Murad will be talking about superbugs, the danger they pose to humanity, and new methods developed by SaNOtize that avoid the use of antibiotics.

Dr. Murad will join other OurCrowd medtech companies in the “High-Tech Horror Show” session that addresses how Armageddon can be postponed as tech tackles our worst fears including disease, climate change, gene tinkering, fake news and cyberhacking.

Other medtech experts appearing at the Summit include:

• Prof. Ruth Arnon, Dept of Immunology, Weizmann Institute, co-creator of the Copaxone treatment for multiple sclerosis and developer of a new universal flu vaccine, who will receive the Maimonides Award for Lifetime Achievement
• Dr. Eran Eden, Co-founder and CEO of MeMed, whose technology enables early prescription and preventing misuse of antibiotics with personalized diagnostics by decoding the human immune system

• Eyal Gura, Co-Founder and chairman of Zebra Medical Vision, which has secured 4 FDA clearances for its AI-powered imaging analytics platform

• Uzi Sofer, CEO and chairman of Alpha Tau, whose Alpha Dart targeted cancer radiation treatment showed tumor shrinkage in 100% of cases in its first clinical trial

For interview opportunities with these and other medtech experts at the OurCrowd Global Investor summit, apply now for your VIP media pass at summit.ourcrowd.com.

About OurCrowd:

OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. With $1.4 billion of committed funding, and investments in 200 portfolio companies and 20 venture funds, OurCrowd offers access to its membership of 41,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms. OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel. To register and get involved, visit www.ourcrowd.com.

About the OurCrowd Global Investor Summit: “Where the startup world gathers”

The 2020 OurCrowd Global Investor Summit is one of the premier events in the tech industry, and the largest business conference in Israel. The 2020 Summit will take place February 13. In 2019, over 18,000 people from 189 countries registered to attend what has become the fastest-growing tech conference in the world. The Summit provides unprecedented insight into the world of startup venture capital, with exclusive exposure to cutting-edge technologies, the entrepreneurs behind them, and the corporate leaders deploying them. Top investors, venture capitalists, corporate partners, entrepreneurs and journalists come from around the world to get business done. The Summit anchors a week of events that include corporate meetups, VC forums, insider access to accelerators and labs, and cultural excursions, as well as nightly opportunities for great food, drink and networking with the global crowd. As Forbes reported, Summit Week in Israel was “the place to be.” Thousands more will participate through livestreaming. Learn more at summit.ourcrowd.com.

For Press Materials: https://blog.ourcrowd.com/murad/